ABCL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ABCLAbCellera Biologics Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ABCLAbCellera Biologics Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ABCL 3

BRKRBrukercustomer

PRLDPrelude Therapeuticssupplier

RLYBRallybiocustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customerSource: SEC EDGAR

25 more · LLY chain ›

ABCLAbCellera Biologics Inc.

11.12▼−9.45%· post 11.16· delayed

Mkt cap$3.8BRevenue$4MQ2 FY26Revenue$75MFY25

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,365.65· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

ABCLAbCellera Biologics Inc.

LLYELI Lilly & Co

11.12▼−9.45%post 11.16delayed

Price

1,371.32▼−3.29%post 1,365.65delayed

$3.8B

Mkt cap

$1.3T

Q2 FY26$4M

Revenue

$24.4BQ3 FY26

FY25$75M

Revenue

$65.2BFY25

ABCL11.12▼−9.45%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed